| The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation CD Waring, C Vicinanza, A Papalamprou, AJ Smith, S Purushothaman, ... European heart journal 35 (39), 2722-2731, 2014 | 225 | 2014 |
| Glycogen content regulates peroxisome proliferator activated receptor-∂(PPAR-∂) activity in rat skeletal muscle A Philp, MG MacKenzie, MY Belew, MC Towler, A Corstorphine, ... PLoS One 8 (10), e77200, 2013 | 40 | 2013 |
| Assessing the Resident Progenitor Cell Population and the Vascularity of the Adult Human Meniscus J Chahla, A Papalamprou, V Chan, Y Arabi, K Salehi, TJ Nelson, ... Arthroscopy: The Journal of Arthroscopic & Related Surgery 37 (1), 252-265, 2021 | 34 | 2021 |
| Xenogeneic cardiac extracellular matrix scaffolds with or without seeded mesenchymal stem cells exhibit distinct in vivo immunosuppressive and regenerative properties A Papalamprou, CW Chang, N Vapniarsky, A Clark, N Walker, LG Griffiths Acta biomaterialia 45, 155-168, 2016 | 22 | 2016 |
| Cardiac extracellular matrix scaffold generated using sarcomeric disassembly and antigen removal A Papalamprou, LG Griffiths Annals of biomedical engineering 44 (4), 1047-1060, 2016 | 13 | 2016 |
| Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration JD Glaeser, P Behrens, T Stefanovic, K Salehi, A Papalamprou, ... Stem cells translational medicine, 2021 | 10 | 2021 |
| Solubilization of antigen components for removal from tissues LG Griffiths, A Papalamprou US Patent 9,220,733, 2015 | 6 | 2015 |
| Solubilization of antigen components for removal from tissues LG Griffiths, A Papalamprou US Patent 9,827,350, 2017 | 4 | 2017 |
| Solubilization of antigen components for removal from tissues LG Griffiths, A Papalamprou US Patent 10,709,813, 2020 | 2* | 2020 |
| Solubilization of antigen components for removal from tissues LG Griffiths, A Papalamprou US Patent App. 16/912,586, 2020 | | 2020 |
| REVISITING THE VASCULARITY AND RESIDENT STEM CELL POPULATION OF THE MENISCAL AVASCULAR ZONE D Sheyn, A Papalamprou, J Chahla, V Chan, O Limpisvasti, ... Orthopaedic Proceedings 102 (SUPP_8), 49-49, 2020 | | 2020 |
| Xenogeneic Scaffolds for Cardiac Tissue Engineering: Antigen Removal and Mesenchymal Stem Cell Immunomodulation A Papalamprou University of California, Davis, 2015 | | 2015 |
| P81Endogenous cardiac stem cell (eCSC) activation, myogenesis and angiogenesis contribute to cardiac remodelling following intensity-controlled exercise training CD Waring, A Papalamprou, S Purushothaman, AJ Smith, C Vicinanza, ... Cardiovascular Research 93 (suppl_1), 2012 | | 2012 |
